Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. TaperAid
WARNING LETTER
•TaperAid

TaperAid – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Richie Ogulnick after reviewing www.taperaid.com and www.facebook.com/TaperAid in December 2017, concerning the products “TaperAid” and “TaperAid Complete.” The FDA determined that claims on these websites establish the products as unapproved new drugs under sections 201(g)(1)(B) and 201(p) of the Federal Food, Drug, and Cosmetic Act (the Act), as they are intended for disease treatment and are not generally recognized as safe and effective. Introducing these unapproved new drugs into interstate commerce violates sections 301(d) and 505(a) of the Act. Additionally, the products are misbranded under section 502(f)(1) of the Act due to a lack of adequate directions for use, as their intended purposes require professional supervision, making their introduction into interstate commerce a violation of section 301(a). The Federal Trade Commission (FTC) also found the marketing claims unsubstantiated, violating Sections 5 and 12 of the FTC Act, which mandates competent and reliable scientific evidence for health claims. The firm must notify FDA and FTC within fifteen working days of specific corrective actions taken, including documentation. Failure to comply could result in legal action, including seizure, injunction, and monetary penalties.

Company
TaperAid
Product type
Food
Office
Center for Food Safety and Applied Nutrition
People
  • Mary K. Engle (Associate Director)
  • William A. Correll (Director)
View Company Profile

ID · 00597f8c-5c2d-4373-86e7-ef3eaa249fc4

Violation Codes8
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 353(b)(1)(A)21 CFR 201.521 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore TaperAid
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.